Lynne E. Rueter
Affiliations: | Abbott Laboratories, Irving, TX, United States |
Area:
depression, schizophrenia, learning/memoryGoogle:
"Lynne Rueter"Mean distance: 15.81 (cluster 19)
Children
Sign in to add traineeMin Zhang | research scientist | 2003- | Abbott Labs |
Michael E. Ballard | research scientist | 2001-2007 | Abbott Labs |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kohlhaas KL, Robb HM, Roderwald VA, et al. (2015) Nicotinic modulation of auditory evoked potential electroencephalography in a rodent neurodevelopmental model of schizophrenia. Biochemical Pharmacology. 97: 482-7 |
Brown JW, Rueter LE, Zhang M. (2014) Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 49: 53-62 |
Brown JW, Whitehead CA, Basso AM, et al. (2013) Preclinical evaluation of non-imidazole histamine H3 receptor antagonists in comparison to atypical antipsychotics for the treatment of cognitive deficits associated with schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 889-904 |
Esbenshade TA, Browman KE, Miller TR, et al. (2012) Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics. 343: 233-45 |
Kohlhaas KL, Bitner RS, Gopalakrishnan M, et al. (2012) Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis. Psychopharmacology. 220: 823-33 |
Lenz RA, Baker JD, Locke C, et al. (2012) The scopolamine model as a pharmacodynamic marker in early drug development. Psychopharmacology. 220: 97-107 |
Mohler EG, Browman KE, Roderwald VA, et al. (2011) Acute inhibition of 11beta-hydroxysteroid dehydrogenase type-1 improves memory in rodent models of cognition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 5406-13 |
Basso AM, Gallagher KB, Mikusa JP, et al. (2011) Vogel conflict test: sex differences and pharmacological validation of the model. Behavioural Brain Research. 218: 174-83 |
Zhang M, Ballard ME, Basso AM, et al. (2011) Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity. Behavioural Brain Research. 217: 81-7 |
Chin CL, Curzon P, Schwartz AJ, et al. (2011) Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia. Synapse (New York, N.Y.). 65: 393-403 |